Nearly 40% of Cancer Clinical Trials Disrupted By COVID-19 Are Restarting; Guidance for Patients

Published Aug 17, 2020

Nearly 40% of Cancer Clinical Trials Disrupted By COVID-19 Are Restarting; Guidance for Patients

Patients and doctors are encouraged that clinical trials have started up again. A leading expert talks to SurvivorNet about why you shouldn't be afraid to consider a clinical trial during the outbreak.

NOW
PLAYING
FDA Approves First Targeted Therapy For Lung Cancer Patients With the KRAS Gene Mutation
NOW
PLAYING
Delayed Cancer Screenings Due to COVID: What to Do Now
NOW
PLAYING
Netflix's 'Halston' Shines a Light on the Designer Who Died from Lung Cancer
NOW
PLAYING
Cancer Patients Should Still Wear Masks & Distance Says Leading Expert - Even in Wake of Major New CDC Guidelines
NOW
PLAYING
Using CAR T-Cell Therapy Earlier
NOW
PLAYING
CART T-Cell Therapy During the COVID-19 Pandemic: Is it Safe?

SurvivorNetTV.
Hope. Science.
Inspiration.

WATCH NOW
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.